Asset Details
Do you wish to reserve the book?
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
Do you wish to request the book?
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
2022
Overview
Opioid agonists are recommended for opioid use disorder in pregnancy. A large cohort study showed that buprenorphine was associated with lower incidences of neonatal abstinence syndrome and complications at birth than methadone.
Publisher
Massachusetts Medical Society
Subject
/ Buprenorphine - adverse effects
/ Buprenorphine - therapeutic use
/ Cesarean Section - statistics & numerical data
/ Codes
/ Female
/ Humans
/ Infant
/ Infant, Small for Gestational Age
/ Infants
/ Medicaid
/ Neonatal abstinence syndrome
/ Neonates
/ Opiate Substitution Treatment - adverse effects
/ Opiate Substitution Treatment - methods
/ Opioid-Related Disorders - drug therapy
/ Opioid-Related Disorders - epidemiology
/ Opioids
/ Pregnancy Complications - drug therapy
/ Pregnancy Complications - epidemiology
/ Pregnancy Outcome - epidemiology
